• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠肝脏二氢嘧啶脱氢酶的昼夜节律。与氟嘧啶化疗的可能关联。

Circadian rhythm of rat liver dihydropyrimidine dehydrogenase. Possible relevance to fluoropyrimidine chemotherapy.

作者信息

Harris B E, Song R L, He Y J, Soong S J, Diasio R B

机构信息

Department of Pharmacology, University of Alabama at Birmingham 35294.

出版信息

Biochem Pharmacol. 1988 Dec 15;37(24):4759-62. doi: 10.1016/0006-2952(88)90349-8.

DOI:10.1016/0006-2952(88)90349-8
PMID:3202908
Abstract

The activity of dihydropyrimidine dehydrogenase (DPD), the initial, rate-limiting enzyme in pyrimidine catabolism, was measured at various times over a 24-hr period in the livers of rats housed under standardized conditions of light and dark. Under "normal" conditions, i.e. lights on from 6:00 a.m. to 6:00 p.m. and off from 6:00 p.m. to 6:00 a.m., a circadian rhythm of DPD activity was observed (P less than 0.0001, Cosinor analysis) with the peak of activity at 4:00 p.m. (2.96 nmol catabolites/min/mg) and the trough at 4:00 a.m. (0.40 nmol catabolites/min/mg). Maximum enzyme activity exceeded minimum activity by more than 7-fold. Reversing the light-dark cycle (i.e. lights on from 6:00 p.m. to 6:00 a.m. and off from 6:00 a.m. to 6:00 p.m.) resulted in a corresponding shift in enzyme activity. Under these "reverse" conditions, a circadian rhythm was observed (P less than 0.0001, Cosinor analysis) with the peak of activity at 6:00 a.m. (2.87 nmol catabolites/min/mg) and the trough at 6:00 p.m. (0.92 nmol catabolites/min/mg). These studies demonstrated that DPD activity in rat liver varies over a 24-hr period in association with the light-dark cycle.

摘要

二氢嘧啶脱氢酶(DPD)是嘧啶分解代谢中的初始限速酶,在处于标准化明暗条件下饲养的大鼠肝脏中,于24小时内的不同时间测量其活性。在“正常”条件下,即上午6:00至下午6:00开灯,下午6:00至上午6:00关灯,观察到DPD活性存在昼夜节律(余弦分析,P小于0.0001),活性峰值出现在下午4:00(2.96纳摩尔分解代谢产物/分钟/毫克),谷值出现在凌晨4:00(0.40纳摩尔分解代谢产物/分钟/毫克)。最大酶活性超过最小活性7倍以上。颠倒明暗周期(即下午6:00至上午6:00开灯,上午6:00至下午6:00关灯)导致酶活性相应改变。在这些“颠倒”条件下,观察到昼夜节律(余弦分析,P小于0.0001),活性峰值出现在上午6:00(2.87纳摩尔分解代谢产物/分钟/毫克),谷值出现在下午6:00(0.92纳摩尔分解代谢产物/分钟/毫克)。这些研究表明,大鼠肝脏中的DPD活性在24小时内随明暗周期而变化。

相似文献

1
Circadian rhythm of rat liver dihydropyrimidine dehydrogenase. Possible relevance to fluoropyrimidine chemotherapy.大鼠肝脏二氢嘧啶脱氢酶的昼夜节律。与氟嘧啶化疗的可能关联。
Biochem Pharmacol. 1988 Dec 15;37(24):4759-62. doi: 10.1016/0006-2952(88)90349-8.
2
Circadian variation of 5-fluorouracil catabolism in isolated perfused rat liver.离体灌注大鼠肝脏中5-氟尿嘧啶分解代谢的昼夜变化。
Cancer Res. 1989 Dec 1;49(23):6610-4.
3
Relationship between circadian-dependent toxicity of 5-fluorodeoxyuridine and circadian rhythms of pyrimidine enzymes: possible relevance to fluoropyrimidine chemotherapy.5-氟脱氧尿苷的昼夜依赖性毒性与嘧啶酶昼夜节律之间的关系:对氟嘧啶化疗的可能相关性。
Cancer Res. 1993 Jun 15;53(12):2816-22.
4
Circadian rhythm of orotate phosphoribosyltransferase, pyrimidine nucleoside phosphorylases and dihydrouracil dehydrogenase in mouse liver. Possible relevance to chemotherapy with 5-fluoropyrimidines.小鼠肝脏中乳清酸磷酸核糖基转移酶、嘧啶核苷磷酸化酶和二氢尿嘧啶脱氢酶的昼夜节律。与5-氟嘧啶化疗的可能关联。
Biochem Pharmacol. 1993 Feb 9;45(3):667-73. doi: 10.1016/0006-2952(93)90141-i.
5
Circadian rhythm of rat spleen cytoplasmic thymidine kinase.大鼠脾脏细胞质胸苷激酶的昼夜节律。
Biochem Pharmacol. 1993 Mar 9;45(5):1115-9. doi: 10.1016/0006-2952(93)90256-v.
6
Dihydropyrimidine dehydrogenase circadian rhythm in mouse liver: comparison between enzyme activity and gene expression.小鼠肝脏中二氢嘧啶脱氢酶的昼夜节律:酶活性与基因表达的比较。
Eur J Cancer. 2003 Apr;39(6):822-8. doi: 10.1016/s0959-8049(02)00598-1.
7
Relationship between dihydropyrimidine dehydrogenase activity and plasma 5-fluorouracil levels with evidence for circadian variation of enzyme activity and plasma drug levels in cancer patients receiving 5-fluorouracil by protracted continuous infusion.接受持续静脉滴注5-氟尿嘧啶的癌症患者中,二氢嘧啶脱氢酶活性与血浆5-氟尿嘧啶水平之间的关系,以及酶活性和血浆药物水平昼夜变化的证据。
Cancer Res. 1990 Jan 1;50(1):197-201.
8
Circadian variation of dihydropyrimidine dehydrogenase mRNA expression in leukocytes and serum cortisol levels in patients with advanced gastrointestinal carcinomas compared to healthy controls.与健康对照相比,晚期胃肠道癌患者白细胞中二氢嘧啶脱氢酶mRNA表达及血清皮质醇水平的昼夜变化。
J Cancer Res Clin Oncol. 2002 Feb;128(2):96-102. doi: 10.1007/s00432-001-0309-y. Epub 2001 Nov 30.
9
Inter- and intraindividual variation in dihydropyrimidine dehydrogenase activity in peripheral blood mononuclear cells.
Cancer Chemother Pharmacol. 1997;40(2):117-25. doi: 10.1007/s002800050635.
10
CPT-11 alters the circadian rhythm of dihydropyrimidine dehydrogenase mRNA in mouse liver.CPT-11改变小鼠肝脏中二氢嘧啶脱氢酶mRNA的昼夜节律。
Jpn J Cancer Res. 2001 May;92(5):554-61. doi: 10.1111/j.1349-7006.2001.tb01129.x.

引用本文的文献

1
DPD status and fluoropyrimidines-based treatment: high activity matters too.DPD 状态与氟嘧啶类药物治疗:高活性也很重要。
BMC Cancer. 2020 May 18;20(1):436. doi: 10.1186/s12885-020-06907-0.
2
Pharmacokinetics of 5-fluorouracil and increased hepatic dihydropyrimidine dehydrogenase activity levels in 1,2-dimethylhydrazine-induced colorectal cancer model rats.1,2-二甲基肼诱导的结直肠癌模型大鼠中5-氟尿嘧啶的药代动力学及肝脏二氢嘧啶脱氢酶活性水平的升高
Eur J Drug Metab Pharmacokinet. 2013 Sep;38(3):171-81. doi: 10.1007/s13318-012-0114-9. Epub 2012 Nov 30.
3
Chronopharmacokinetics of ciclosporin and tacrolimus.
环孢素和他克莫司的时辰药代动力学。
Clin Pharmacokinet. 2006;45(8):775-88. doi: 10.2165/00003088-200645080-00002.
4
Circadian rhythm of dihydrouracil/uracil ratios in biological fluids: a potential biomarker for dihydropyrimidine dehydrogenase levels.生物体液中二氢尿嘧啶/尿嘧啶比率的昼夜节律:二氢嘧啶脱氢酶水平的潜在生物标志物。
Br J Pharmacol. 2004 Feb;141(4):616-23. doi: 10.1038/sj.bjp.0705651. Epub 2004 Jan 26.
5
CPT-11 alters the circadian rhythm of dihydropyrimidine dehydrogenase mRNA in mouse liver.CPT-11改变小鼠肝脏中二氢嘧啶脱氢酶mRNA的昼夜节律。
Jpn J Cancer Res. 2001 May;92(5):554-61. doi: 10.1111/j.1349-7006.2001.tb01129.x.
6
Can pharmacokinetic monitoring improve clinical use of fluorouracil?药代动力学监测能否改善氟尿嘧啶的临床应用?
Clin Pharmacokinet. 1999 Jun;36(6):391-8. doi: 10.2165/00003088-199936060-00001.
7
Sorivudine and 5-fluorouracil; a clinically significant drug-drug interaction due to inhibition of dihydropyrimidine dehydrogenase.索立夫定与5-氟尿嘧啶;因二氢嘧啶脱氢酶受抑制而产生的具有临床意义的药物相互作用。
Br J Clin Pharmacol. 1998 Jul;46(1):1-4. doi: 10.1046/j.1365-2125.1998.00050.x.
8
Phase I study of 5-fluorouracil and leucovorin by a 14-day circadian infusion in metastatic adenocarcinoma patients.转移性腺癌患者中5-氟尿嘧啶和亚叶酸钙14天昼夜输注的I期研究。
Cancer Chemother Pharmacol. 1993;33(3):221-8. doi: 10.1007/BF00686220.
9
Clinical pharmacology of 5-fluorouracil.5-氟尿嘧啶的临床药理学
Clin Pharmacokinet. 1989 Apr;16(4):215-37. doi: 10.2165/00003088-198916040-00002.